Sponsor
IGI Therapeutics S.A.
Rue Du Puits-Godet 8, 2000
About the sponsor
IGI Therapeutics S.A. is involved in clinical research focused on relapsed/refractory multiple myeloma, addressing a difficult-to-treat plasma cell malignancy with unmet therapeutic need.
- Multiple myeloma
- Relapsed disease
- Refractory disease
The sponsor’s research activity is centered on advancing treatment options for patients whose disease has returned or no longer responds to prior therapy.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.